# Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma

> **NCT01455363** · NA · COMPLETED · sponsor: **Institut Curie** · enrollment: 12 (actual)

## Conditions studied

- Carcinoma, Basal Cell

## Interventions

- **PROCEDURE:** BCC surgery
- **OTHER:** Tourniquet ischemia
- **OTHER:** Laser speckle imaging

## Key facts

- **NCT ID:** NCT01455363
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455363, "Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01455363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*